<?xml version="1.0"?>
<Articles JournalTitle="International Journal of Hematology-Oncology and Stem Cell Research">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>International Journal of Hematology-Oncology and Stem Cell Research</JournalTitle>
      <Issn>2008-2207</Issn>
      <Volume>15</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2021</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The RHD Genotyping of Rh-Negative and Weak D Phenotype among Blood Donors in Southeast Iran</title>
    <FirstPage>213</FirstPage>
    <LastPage>220</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Younes</FirstName>
        <LastName>Sadeghi-Bojd</LastName>
        <affiliation locale="en_US">Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Naser</FirstName>
        <LastName>Amirizadeh</LastName>
        <affiliation locale="en_US">Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Arezoo</FirstName>
        <LastName>Oodi</LastName>
        <affiliation locale="en_US">Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>05</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2020</Year>
        <Month>08</Month>
        <Day>31</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: The D antigen is a subset of Rh blood group antigens involved in the hemolytic disease of the newborn [HDFN] and hemolytic transfusion reaction [HTR]. The hybrid Rhesus box that was created after RH gene deletion, was known as a mechanism of the Rh-negative phenotype. Hybrid marker identification is used to confirm the deletion of the RHD gene and to determine zygosity. This study aims to detect this marker in Rh-negative and weak D phenotype blood donors of the southeast of Iran.
&#xD;

Materials and Methods: The molecular analysis of the hybrid Rhesus box was performed on the 200 Rh-negative blood donors in Sistan and Baluchestan province, southeast Iran. The presence of alleles responsible for the D variants was assessed by DNA sequencing in 26 weak D phenotype donors.
&#xD;

Results: Of the 200 Rh-negative blood samples, 198 samples were homozygous (99%), and two samples were heterozygous (1%). Heterozygous samples had RHD*01N.73 allele and the RHD*01N.18 allele. Of the 26 samples with weak D phenotype, 16 partial DLO (61%), 4 partial DBT1 (15.3%), 2 partial DV type 2 (7.7%), 1 weak D type 1, 1 weak D type 4.2.3, 1weak D type 105 and 1 RHD (S103P) (4%) were determined.
&#xD;

Conclusion: Since RHD gene deletion is the main mechanism of the Rh-negativity in Sistan and Baluchestan provinces, a hybrid Rhesus box marker can be used in resolving RhD typing discrepancies by RHD genotyping methods.</abstract>
    <web_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1335</web_url>
    <pdf_url>https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/download/1335/887</pdf_url>
  </Article>
</Articles>
